2019 Annual Meeting Education Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Patents, Royalties, Travel, Stock and Other Expert Name Employment Leadership Honoraria Consulting or Advisory Role Speakers' Bureau Research Funding Other Intellectual Accommodations, Other Ownership Interests Testimony Property Expenses Monica M. Abbvie (Inst), Agenus (Inst), Astellas Bertagnolli Pharma (Inst), AstraZeneca (Inst), Baxalta (Inst), Bayer Health (Inst), Breast Cancer Research Foundation (Inst), Bristol- Myers Squibb (Inst), Celgene (Inst), Complion (Inst), Eisai (Inst), (Inst), (Inst), GHI Pharma (Inst), (Inst), GlaxoSmithKline (Inst), Incyte (Inst), Janssen (Inst), (Inst), Leidos (Inst), Lexicon (Inst), Lilly (Inst), Matrex (Inst), Mayo Clinic (Inst), Merck (Inst), MGH (Inst), Millenium Pharamceuticals (Inst), (Inst), PCORI (Inst), (Inst), Pharmacyclics (Inst), Robert Wood Johnson Foundation (Inst), Sagerock Advisors (Inst), Sanofi (Inst), Taiho Oncology (Inst), Takeda (Inst), Tesaro (Inst), Teva (Inst)

Tatiana M. Prowell David R. Spigel AstraZeneca (Inst), Boehringer AstraZeneca (Inst), (Inst), Bristol-Myers Ingelheim (Inst), Bristol-Myers Squibb Squibb (Inst), Celgene (Inst), (Inst), Celgene (Inst), Genentech/Roche Genentech/Roche (Inst), (Inst), Lilly (Inst), Merck (Inst), Novartis Novartis (Inst), Pfizer (Inst) (Inst), Pfizer (Inst), University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)

Colin D. Weekes Celgene, Lilly, Merrimack Celgene, Merrimack Abbvie, Bayer, Celgene, Genentech/Roche, Lilly, Millennium Breast Cancer Neelima Denduluri (Inst), Genentech (Inst), Novartis (Inst) Rebecca A. Dent AstraZeneca, Lilly, Pfizer, AstraZeneca, Eisai, Merck, Amgen, Pfizer, Roche Roche/ Pfizer, Roche Genentech Kelly Hunt Armada Health Care Endomagnetics (Inst) Sara A. Hurvitz Ambryx (Inst), Amgen (Inst), Bayer (Inst), Lilly, Novartis, OBI Biomarin (Inst), Boehringer Ingelheim Pharma (Inst), Cascadian Therapeutics (Inst), Daiichi Sankyo (Inst), Dignitana (Inst), Genentech/Roche (Inst), GlaxoSmithKline (Inst), Lilly (Inst), Macrogenics (Inst), Medivation (Inst), Merrimack (Inst), Novartis (Inst), OBI Pharma (Inst), Pfizer (Inst), Puma (Inst), Sanofi (Inst), Seattle Genetics (Inst)

Alberto J. Montero Johnson & Johnson Celgene New Century Health Stacy L. Moulder Novartis Bayer (Inst), Genentech (Inst), Novartis Novartis (Inst), Oncothyreon (Inst), Pfizer (Inst), Takeda (Inst) Erica M. Stringer- Breast Cancer Index, Lilly Immunomedics Susan G. Komen for the Cure Cascadian Reasor Therapeutics Alexandra Thomas Gilead Sciences, BeyondSpring Pharmaceuticals Syndax (Inst) Up-to-Date Royalties (I) Johnson & Johnson (I) Cancer Prevention, Hereditary Genetics, and Epidemiology Banu Arun Abbvie, PharmaMar Jeff Boyd Joanne M. Jeter Pfizer Bristol-Myers Squibb, Merck Pfizer Sailaja Kamaraju Prudence B. Lam Myriad Genetics Howard L. McLeod Cancer Genetics, Genentech/Roche Cancer Genetics, Gentris, Interpares Biomedicine NIH/NCI, Saladax Biomedical

Michael P. Mullane

Victoria L. Seewaldt

Gina M. Villani Anthony Alberg (Liaison) Care Delivery and Practice Management Edward Arrowsmith Tennessee Flatiron Health Flatiron Health Sarah Oncology Cannon Research Suzanne Cole Research to Practice Robert M. Daly Quadrant CVS Health, Johnson & Holdings Johnson, Lilly (I), McKesson, Quadrant Holdings (I), (I), Walgreens Boots Alliance

Kurt C. Demel Gilead Sciences, Pfizer Sue Sun Yom BioMimetix Bristol-Myers Squibb (Inst), Genentech UpToDate, Springer (Inst), Merck (Inst) Paul Celano (Liaison) Leonard Saltz McNeil PPC (I) Taiho Pharmaceutical (Liaison) Central Nervous System Tumors Tracy Batchelor Champions, Amgen, GenomiCare, Merck, Genomicare, Merck, Biotechnology, NXDC Roche/Genentech Genomicare, Imedex, Merck, NXDC, UpToDate Priscilla K. Angiochem, Genentech, Angiochem, Genentech/ Merck, Pfizer Brastianos Merck Roche, Lilly

Simon S. Lo Ingo K. Mellinghoff Developmental Immunotherapy and Tumor Immunobiology Todd M. Bauer Sarah Cannon Guardant Health, Ignyta (Inst), Abbvie (Inst), Aileron Therapeutics (Inst), Research Loxo, Amgen (Inst), Astellas Pharma (Inst), Institute, Therapeutics (Inst), AstraZeneca (Inst), Boehringer Tennessee Pfizer Ingelheim (Inst), Bristol-Myers Squibb Oncology (Inst), Calithera Biosciences (Inst), Clovis Oncology (Inst), Daiichi Sankyo (Inst), Deciphera (Inst), Five Prime Therapeutics (Inst), Foundation Medicine (Inst), Genentech/Roche (Inst), GlaxoSmithKline (Inst), Ignyta (Inst), Immunocore (Inst), Immunogen (Inst), Incyte (Inst), Jacobio (Inst), Janssen (Inst), Karyopharm Therapeutics (Inst), Kolltan Pharmaceuticals (Inst), Leap Therapeutics (Inst), Lilly (Inst), Loxo (Inst), MabVax (Inst), MedImmune (Inst), Medpacto (Inst), Merck (Inst), Merrimack (Inst), Millennium (Inst), Mirati Therapeutics (Inst), Moderna Therapeutics (Inst), Novartis (Inst), Onyx (Inst), Peleton (Inst), Pfizer (Inst), Phosplatin Therapeutics (Inst), Principa Biopharma (Inst), Roche (Inst), Sanofi (Inst), Stemline Therapeutics (Inst), Takeda (Inst), Top Alliance BioScience (Inst)

Benjamin Besse AstraZeneca (Inst), Boehringer Bristol-Myers Ingelheim (Inst), Bristol-Myers Squibb Squibb/Medarex, (Inst), Inivata (Inst), Lilly (Inst), Loxo Novartis, Pfizer, Pierre (Inst), Novartis (Inst), OncoMed (Inst), Fabre, Roche Onxeo (Inst), Ose Pharma (Inst), Pfizer (Inst), Roche/Genentech (Inst), SERVIER (Inst) Scott N. Gettinger , ARIAD (Inst), Bristol-Myers Squibb (Inst), Merck Bristol-Myers Squibb, Genentech (Inst), Incyte (Inst), Pfizer Pfizer (Inst) Naoko Takebe Lei Zheng Z and L International AstraZeneca, Biosynergies, Amgen,Bristol-Myers Squibb, Gradalis, GVAX, licensed to Medical Merck, Merrimack, Novarock Halozyme, ITeos Therapeutics, Merck Aduro Biotech

Lajos Pusztai Merck, AstraZeneca/ H3 Biomedicine, Merck, Merck, Genentech, Seattle Genetics, (Liaison) MedImmune, Pfizer, Novartis, PierianDx, Seattle AstraZeneca Syndax, Almac Genetics, Syndax Diagnostics, Pieris Pharmaceuticals, Genentech, Immunomedics, Eisai, Seattle Genetics/Astellas

Developmental Therapeutics and Tumor Biology and (Nonimmuno) Ryan B. Corcoran Amgen, Astex Pharmaceuticals, AstraZeneca, Sanofi Avidity Nanomedicines, Bristol- Myers Squibb, FOG Pharma, Genentech, Loxo, Merrimack, N- of-One, Roche, Roivant, Shire, , Symphogen, Taiho Pharmaceutical, Warp Drive Bio

David S. Hong MolecularMatch, Adaptimmune, Baxter, Bayer, Eisai, Abbvie, Adaptimmune, Amgen, Loxo, miRNA Oncorena Baxter, Bayer, Merrimack Genentech, GLG, Guidepoint AstraZeneca, Bayer, Bristol-Myers Therapeutics Global, Janssen Squibb, Daichii Sankyo, Eisai, Genentech, Genmab, Ignyta, Infinity Pharmaceuticals, , Kyowa Hakko Kirin, Lilly, Loxo, MedImmune, Merck, Mirati Therapeutics, miRNA Therapeutics, Molecular Templates, Novartis, Pfizer, Seattle Genetics, Takeda

Victoria M. Villaflor ARIAD/Takeda, AstraZeneca, ARIAD/Takeda, Genentech/Roche AstraZeneca

Kwok-Kin Wong G1 Therapeutics Array BioPharma, AstraZeneca, Gilead Sciences, AstraZeneca, Genocea GlaxoSmithKline, Janssen Oncology Biosciences, Janssen (Inst), Janssen Oncology, Lilly Oncology, Lilly, Novartis, Ono Pharmaceutical Gastrointestinal (Colorectal) Cancer Nilofer S. Azad AMAG Pharmaceuticals, AMAG Pharmaceuticals, Agios (Inst), Array BioPharma (Inst), Bayer/Onyx DAVA Oncology Astex Pharmaceuticals (Inst), Bristol- Myers Squibb (Inst), Celgene (Inst), Genentech (Inst), Intensity Therapeutics, Merck (Inst), Syndax (Inst)

Sharlene Gill Amgen, Bristol-Myers Squibb, Taiho Pharmaceutical Celgene Celgene, Lilly, Shire, Taiho Pharmaceutical Arden M. Morris Michael J. Overman Bristol-Myers Squibb, Amgen, Bristol-Myers Squibb, Celgene, Merrimack, Roche/Genentech MedImmune, Merck, Roche

Weijing Sun Genentech/Roche, Bayer Bayer, Merck (Inst) Taiho Pharmaceutical Gastrointestinal (Noncolorectal) Cancer Ian Chau Gilead Sciences, Lilly Bristol-Myers Squibb, Lilly, Janssen-Cilag (Inst), Lilly (Inst), Merck Bristol-Myers Squibb, Merck Serono, MSD Oncology Serono (Inst), Sanofi (Inst) Lilly, Merck Serono, MSD, Sanofi Ramon A. De Mello AstraZeneca, Novartis MSD Oncology, Pfizer AstraZeneca Amgen, AstraZeneca, Zodiac Merck, Pierre Fabre, Roche

Peter C. Enzinger Astellas Pharma, Five Prime Therapeutics, Merck, Taiho Pharmaceutical Lipika Goyal Taiho Pharmaceutical Taiho Pharmaceutical James Posey Circulogene Lilly Theranostics Federico A. Sanchez Via Oncology

Genitourinary (Nonprostate) Cancer Jeanny B. Aragon- Bristol-Myers Squibb Algeta/Bayer, AstraZeneca, Astellas Pharma, Bristol- Algeta/Bayer, Ching Dendreon, Myers Squibb, Janssen- Dendreon Ortho James Brugarolas Nektar Genentech/Roche Patent of HIF-2 Nektar biomarker (Inst) Primo Lara Pfizer Abbvie, AstraZeneca, Bayer, Aragon Pharmaceuticals (Inst), Bristol-Myers Squibb, CellMax Genentech (Inst), GlaxoSmithKline (Inst), Life, Exelixis, Foundation Heat Biologics (Inst), Incyte (Inst), Medicine, Genentech/Roche, Janssen Biotech (Inst), Merck (Inst), Janssen, Merck, Nektar, Pfizer, Millennium (Inst), Pharmacyclics (Inst), Turnstone Bio Polaris (Inst), TRACON Pharma (Inst)

Bradley A. McGregor Astellas Pharma, AstraZeneca, Bayer, Exelixis, Genentech/Roche, Nextar, Seattle, Genetics/Astellas

Evan Y. Yu Amgen, AstraZeneca, Bayer, Agensys (Inst), Astellas Pharma (Inst), Churchill, Pharmaceuticals, Bayer (Inst), Dendreon (Inst), EMD Serono, Incyte, Janssen, Genentech/Roche (Inst), Merck (Inst), Merck, QED, Tolmar Seattle Genetics (Inst) Genitourinary (Prostate) Cancer Mark T. Fleming Virginia Genentech, Genentech, Oncology Janssen Oncology Medivation/Astellas Associates Matt D. Galsky Dual Therapeutics Astellas Pharma, BioMotiv, Bristol-Myers Squibb (Inst), Dendreon Methods and Astellas Pharma, Bristol-Myers Squibb, (Inst), Janssen Oncology (Inst), Merck Compositions For BioMotiv, Dendreon, Dendreon, Genentech, (Inst), Novartis (Inst) Treating Cancer and Merck GlaxoSmithKline, Janssen, Lilly, Related Methods. Merck Mount Sinai School of Medicine; July 2012 Joshua Meeks Epizyme Alicia K. Morgans AstraZeneca, Genentech, Astellas Pharma, AstraZeneca, Janssen, Bayer, Genentech, Sanofi Sanofi Geriatric Oncology Gretchen G. Boehringer Ingelheim Eisai Abraxis BioScience (Inst), Bristol-Myers Genomic Health, Kimmick Squibb (Inst), Genentech (Inst), Other (I) GlaxoSmithKline (Inst), Johnson & Johnson (Inst), Novartis (Inst), Puma Biotechnology (Inst), Roche (Inst), (Inst)

Heidi D. Klepin Genentech UptoDate Armin Shahrokni Tanya M. Wildes Carevive Systems Janssen Oncology (Inst) Global Health Yuko Kitagawa Asahi Kasei, Chugai Ajinomoto (Inst), Asahi Kasei (Inst), Pharma, , Astellas Pharma (Inst), Boehringer Nippon Kayaku, Olympus, Ingelheim (Inst), Chugai Pharma (Inst), Ono Pharmaceutical, CSL Behring (Inst), Daiichi Sankyo (Inst), Taiho Pharmaceutical Dainippon Sumitomo Pharma (Inst), EA Pharma (Inst), GlaxoSmithKline (Inst), Kaken Pharmaceutical (Inst), Kowa (Inst), Kureha (Inst), Kyowa Hakko Kirin (Inst), Lilly (Inst), Medicon (Inst), Medtronic (Inst), Merck Serono (Inst), Nippon Kayaku (Inst), Novartis (Inst), Otsuka (Inst), Pfizer (Inst),Sanofi (Inst), (Inst), Taiho Pharmaceutical (Inst), Taisho Toyama Pharma (Inst), Takeda (Inst), Teijin Pharma (Inst), Tsumura & Co. (Inst), Yakult Honsha (Inst)

Gilberto Lopes Pfizer AstraZeneca (Inst), AstraZeneca, Bavarian Nordic (Inst), Blueprint Medicines (Inst), EMD Serono (Inst), G1 Therapeutics (Inst), Merck Sharp & Dohme (Inst), NOVARTIS (Inst), Tesaro (Inst) Alex Mutombo Baleka Hans Wildiers Amgen, Celldex, Encore Amgen, Janssen, Encore Medical, LEO Roche, Teva Pfizer, Roche, LEO Pharma, Pfizer, Medical, Novartis, Pfizer, OncologyLive, Pfizer, Puma Pharma, Pfizer, Roche, TRM Puma Biotechnology, Roche, TRM Oncology Biotechnology, Roche, Teva TRM Oncology Oncology Roche Razvan Popescu Roche (Inst), Novartis (Inst), Roche (Inst), Sanofi (Inst), Abbvie (Inst) (Liaison) Merck Sharpe & Dohme (Inst), Merck (Inst), Lily (Inst), Bristol- Myers Squibb (Inst)

Gynecologic Cancer Ronald J. Tradewinds Bioscience Mersana Cerulean Pharma (Inst), Tesaro (Inst) Buckanovich Elizabeth L. Dickson

Kathleen N. Moore Advaxis, AstraZeneca (Inst), Lilly (Inst), PTC Therapeutics (Inst) Genentech/Roche Clovis Oncology (Inst), Genentech/Roche (Inst), Immunogen (Inst), Janssen Oncology (Inst), TESARO (Inst), VBL Therapeutics (Inst)

Amit M. Oza Intas AstraZeneca (Inst), Immunovaccine AstraZeneca (Inst) Head and Neck Cancer Nishant Agrawal Muralidhar Beeram Genentech Novartis (I) Genentech

Hisham M. Mehanna Warwickshire Warwickshire Warwickshire Head and AstraZeneca Merck, MSD, Sanofi AstraZeneca, GlaxoSmithKline (Inst), Merck, MSD, Sanofi Head and Neck Head and Neck Clinic Pasteur MSD (Inst), Sanofi Pasteur (Inst), Pasteur Clinic Neck Clinic, (Inst) Warwickshire Head and Neck Clinic (I)

Lori J. Wirth Amgen, Blueprint Medicines, Eisai, Loxo, Merck, Novartis

Health Services Research, Clinical Informatics & Quality of Care Michael T. Halpern Solstice Health Abbvie Communications Aaron P. Mitchell Ryan D. Nipp Katherine S. Virgo Jeremy Warner HemOnc.org Yousuf Zafar Novartis (I) Novartis (I) AIM Specialty Health, AstraZeneca (Inst) Family Reach Foundation, Vivor Ana Maria Lopez (Liaison) Matthew Katz McKesson, Alcresta (Liaison) Therapeutics, Abbvie Inga Lennes Blue Cross and Blue Kyruus (Liaison) Shield of Massachusetts Hematologic Malignancies-Leukemia, MDS, and Allotransplant Aref Al-Kali Ambit BioSciences (Inst), Astex Pharmaceuticals (Inst), Bristol-Myers Squibb (Inst), Celgene (Inst), H3 Biomedicine (Inst), MedImmune (Inst), Novartis (Inst), Onconova Therapeutics (Inst) Asad Bashey Elihu Estey Catriona H. Impact Iimpact Biomedicines (I), Impact Biomedicines (I) Johnson & Johnson, Celgene (Inst) Forty Seven (I) Jamieson Biomedicines Forty Seven (I) (I) Milos Miljkovic Hematologic Malignancies-Lymphoma and CLL Jeremy S. Abramson Amgen, Celgene, Celgene (Inst, Genentech (Inst), Juno Genentech/Roche, Gilead Therapeutics (Inst), Seattle Genetics Sciences, Juno Therapeutics, (Inst) Karyopharm Therapeutics, Kite Pharma, Novartis, Seattle Genetics, Verastem Carla Casulo Gilead Sciences Celgene (Inst) Gilead Sciences, Roche

Nilanjan Ghosh Janssen, Juno Therapeutics, Abbvie, Celgene, Gilead Bristol-Myers Squibb (Inst), Celgene Kite Pharma, Spectrum, Sciences, Janssen (Inst), Forty Seven (Inst), Pharmaceuticals Oncology Genentech/Roche (Inst), Janssen (Inst), Juno Therapeutics (Inst), Pharmacyclics (Inst), Seattle Genetics (Inst), TG Therapeutics (Inst)

Ishmael A. Jaiyesimi

Barbara Pro Celgene, Kiowa, Celgene (Inst), Takeda (Inst) Seattle Genetics, Seattle Genetics, Takeda Takeda

Hematologic Malignancies-Plasma Cell Dyscrasia Anuj K. Mahindra Amgen Amgen, Janssen Bristol-Myers Squibb, Celgene, Oncology, Sanofi Genentech/Roche, Janssen Oncology, Takeda Sham Mailankody Weber Shandwick Joseph Mikhael Abbvie (Inst), Celgene (Inst), Sanofi (Inst) Ashley E. Rosko Medscape, Onclive Abbvie (Inst), Acetylon (Inst), Janssen (Inst), Merck (Inst), Takeda (Inst)

Saad Z. Usmani Amgen, Celgene, Janssen Amgen, Celgene, Takeda Array BioPharma, Celgene, Janssen Oncology Oncology, Millennium, Onyx, Pharmacyclics, Sanofi Lung Cancer Shruti Jolly Varian Medical Systems AstraZeneca

Mark G. Kris AstraZeneca, Pfizer, Regeneron Christopher S. PER Bristol-Myers Squibb, CVS Health Lathan Gerson Lehrman Group, Lilly Taofeek K. Abbvie, Bristol-Myers Squibb, Abbvie (Inst), Astellas Pharma (Inst), Overcoming Aquired Owonikoko Celgene, Eisai, G1 AstraZeneca/MedImmune (Inst), Bayer Resistance to Therapeutics, Lilly, (Inst), Bristol-Myers Squibb (Inst), Chemotherapy MedImmune, Novartis, Sandoz, Celgene (Inst), G1 Therapeutics (Inst), Treatments Through Seattle Genetics, Takeda Novartis (Inst), Regeneron (Inst), Stem Supression of STAT3 CentRx (Inst) (Inst); Selective Chemotherapy Treatments and Diagnostic Methods Related Thereto (Inst) Nathan A. Pennell AstraZeneca, Cota Healthcare, AstraZeneca (Inst), Boehringer Lilly, Regeneron Ingelheim (Inst), Celgene (Inst), Genentech (Inst), Loxo (Inst), Merck, Pfizer (Inst) Anne S. Tsao ARIAD, Astellas Pharma, Boehringer Ingelheim (Inst), Bristol- UptoDate AstraZeneca/Med-Immune, Myers Squibb (Inst), Genentech/Roche Boehringer Ingelheim, Bristol- (Inst), MedImmune (Inst), Merck (Inst), Myers Squibb, EMD Serono, Millennium, Polaris, Seattle Genetics Epizyme, Genentech/Roche, Imedex, Lilly, MedImmune, Novartis /Skin Cancers Rodabe N. Amaria Array BioPharma (Inst), Bristol-Myers Squibb (Inst), Genentech (Inst) Merck (Inst), Novartis (Inst) Paolo A. Ascierto Amgen, Array BioPharma, Array BioPharma (Inst), Bristol-Myers AstraZeneca, Bristol-Myers Squibb (Inst), Roche/Genentech (Inst) Squibb,Genmab, Idera, Incyte, MedImmune, Merck Serono, Merck Sharp & Dohme, Newlink Genetics, Novartis, Pierre Fabre, Roche/Genentech, Sanofi, Sun Pharma, Syndax, Ultimovacs Ragini R. Bristol-Myers Squibb Array BioPharma, Bristol-Myers Merck Kudchadkar Squibb, Novartis Eduardo M. Pharmacyclics, AstraZeneca, Pharmacyclics, Seattle Sotomayor Bayer, Kite Pharma, Celgene, Genetics Genentech/Roche, Seattle Genetics

Ryan J. Sullivan Roche/Genentech ACI Clinical, Amgen, Array Aeglea Biotherapeutics (Inst), Amgen Boehringer BioPharma, Biodesix, (Inst), Asana Biosciences (Inst), BioMed Ingelheim BiolineRx, Compugen, Merck, Valley Discoveries (Inst), Deciphera Novartis, Replimmune, Syndax, (Inst), Lilly (Inst), Merck (Inst), Moderna Takeda, WorldCare Clinical Therapeutics (Inst), Roche/Genentech (Inst), Sanofi (Inst) Pediatric Oncology Sung Won Choi

Paul D. Harker- Merck (I) Murray

Margaret Macy GE Healthcare, Johnson & Ventana Medical Systems Patent for non-invasive Johnson, Teva, Varian methods of leukemia Medical Systems cell detection with MRI/MRS

Michael V. Ortiz Professional Development Vyshak Alva Venur

Brian C. Boulmay Rachel J. Potent Agelastatin Buchsbaum Derivatives as Modulators for Cancer Invasion and Metastasis; Provisional patent application- application in collaboration with Dr. Mohammad Movassaghi (Inst)

Jane L. Meisel Thomas H. Openshaw Sorbarikor Piawah Sarcoma Mark Agulnik Eisai, Janssen, Lilly, Novartis Bristol-Myers Squibb, Eisai, Janssen William D. Tap Atropos Atropos, Agios, Blueprint Medicines, Blueprint Medicines, Daiichi Sankyo, Methods of Treating Pharma- Certis Oncology Solutions Daiichi Sankyo, Eisai, EMD Immune Design, Lilly, Novartis, Metastatic Sarcoma ceuticals, Serono, GlaxoSmithKline, Plexxikon, TRACON Pharma Using Talimogene Certis Immune Design, Janssen, Lilly, Laherparepvec (T-Vec) Oncology Loxo, Novartis, Plexxikon and Solutions Combination Therapy; Companion Diagnostic for CDK4 inhibitors

Jonathan C. Trent GlaxoSmithKline Janssen, Lilly, Novartis

Nicholas P. Webber

Symptoms and Survivorship Norah L. Henry Abbvie (Inst), BioMarin (Inst), Innocrin Pharma (Inst), Pfizer (Inst) Maryam B. Lustberg PledPharma, Tempus Hologic/ Cynosure Amy R. MacKenzie Tenet Healthcare (I)

Kathi Mooney Kevin C. Oeffinger Patricia A. Robinson Amgen Amgen

Jennifer S. Temel Pfizer (Inst) Tara Henderson Seattle (Liaison) Seattle Genetics Genetics Fay Hlubocky (Liaison)